<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Strengths and weaknesses of the Bissau HIV and the Guinea-Bissau police cohorts and associated research teams</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Strengths</th>
    <th align="left">Weaknesses</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">World’s largest HIV-2 cohort + professional cohort with long and frequent follow-up [
     <xref ref-type="bibr" rid="CR4">4</xref>, 
     <xref ref-type="bibr" rid="CR12">12</xref>, 
     <xref ref-type="bibr" rid="CR98">98</xref>, 
     <xref ref-type="bibr" rid="CR130">130</xref>, 
     <xref ref-type="bibr" rid="CR131">131</xref>]
    </td>
    <td align="left">High mortality and loss-to-follow-up</td>
   </tr>
   <tr>
    <td align="left">HIV-2 epidemiology well-characterized over three decades [
     <xref ref-type="bibr" rid="CR4">4</xref>, 
     <xref ref-type="bibr" rid="CR22">22</xref>]
    </td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Nationwide cohort [
     <xref ref-type="bibr" rid="CR131">131</xref>, 
     <xref ref-type="bibr" rid="CR132">132</xref>]
    </td>
    <td align="left">High patient-turnaround and insufficient staff-resources</td>
   </tr>
   <tr>
    <td align="left">Strong collaboration with the National Health Laboratory in Guinea-Bissau</td>
    <td align="left">Limited lab capacity locally</td>
   </tr>
   <tr>
    <td align="left">Large biorepository with preserved plasma and DNA</td>
    <td align="left">Limited sample volume in historical samples</td>
   </tr>
   <tr>
    <td align="left">Cohort clinical real-time database including demographics and follow-up data [
     <xref ref-type="bibr" rid="CR24">24</xref>, 
     <xref ref-type="bibr" rid="CR133">133</xref>–
     <xref ref-type="bibr" rid="CR135">135</xref>]
    </td>
    <td align="left">Limited data-entry capacity and political instability [
     <xref ref-type="bibr" rid="CR136">136</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Close linkage with HIV-cure research environment and in-depth molecular analysis, including access to humanized mice models, ex vivo infection models, full-length genome sequencing and construction of infectious chimeric viruses [
     <xref ref-type="bibr" rid="CR35">35</xref>, 
     <xref ref-type="bibr" rid="CR98">98</xref>, 
     <xref ref-type="bibr" rid="CR137">137</xref>–
     <xref ref-type="bibr" rid="CR141">141</xref>]
    </td>
    <td align="left">Weak local research environment with few nationals at Ph.D level</td>
   </tr>
   <tr>
    <td align="left">Well-functioning national ethical committee with enhanced understanding for the complex ethical balancing needed for cure trials</td>
    <td align="left">Low health literacy among HIV patients, and extended information and consent procedure needed</td>
   </tr>
   <tr>
    <td align="left">National ethics committee placed within Ministry of Health, and a permission also serves as official government authorization for interventions to be tested</td>
    <td align="left">Limited experience among official health authorities for approval of non-approved drugs</td>
   </tr>
   <tr>
    <td align="left">Burden of co-infections and other comorbidities [
     <xref ref-type="bibr" rid="CR98">98</xref>, 
     <xref ref-type="bibr" rid="CR136">136</xref>, 
     <xref ref-type="bibr" rid="CR142">142</xref>–
     <xref ref-type="bibr" rid="CR151">151</xref>]
    </td>
    <td align="left">Limited local diagnostic capacity for a number of co-infections</td>
   </tr>
   <tr>
    <td align="left">Resistance testing of HIV-1 [
     <xref ref-type="bibr" rid="CR152">152</xref>, 
     <xref ref-type="bibr" rid="CR153">153</xref>]
    </td>
    <td align="left">Limited local capacity for genotypic resistance, and non-existing for HIV-2</td>
   </tr>
   <tr>
    <td align="left">Well-described algorithms for the diagnostic challenges of differentiating HIV-2 and dual-infections [
     <xref ref-type="bibr" rid="CR98">98</xref>, 
     <xref ref-type="bibr" rid="CR154">154</xref>–
     <xref ref-type="bibr" rid="CR160">160</xref>]
    </td>
    <td align="left">Not the entire cohort tested with updated HIV-2 and HIV-1/HIV-2 dual diagnostics, needs retesting prior to trials</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
